STOCK TITAN

Amgen (AMGN) SVP reports 225-share tax-withholding stock disposals

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Amgen Inc. SVP Rachna Khosla reported routine tax-withholding share dispositions. On May 2, 2026, a total of 225 shares of Amgen common stock were withheld at $329.82 per share to cover tax liabilities tied to equity awards, not as open-market sales. She continues to hold a direct stake in Amgen stock, and her holdings also reflect 73 dividend equivalents linked to unvested restricted stock units that will settle in shares as they vest.

Positive

  • None.

Negative

  • None.
Insider Khosla Rachna
Role SVP, Business Development
Type Security Shares Price Value
Tax Withholding Common Stock 117 $329.82 $39K
Tax Withholding Common Stock 108 $329.82 $36K
Holdings After Transaction: Common Stock — 8,174 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Tax-withholding shares 225 shares Total common shares disposed for tax withholding on May 2, 2026
First withholding lot 108 shares at $329.82/share Common stock disposition coded F on May 2, 2026
Second withholding lot 117 shares at $329.82/share Common stock disposition coded F on May 2, 2026
Shares following one transaction 8,066 shares Direct common stock ownership after one withholding entry
Shares following other transaction 8,174 shares Direct common stock ownership after the other withholding entry
Dividend equivalents 73 DEs Will be paid in Amgen common stock as RSUs vest
Dividend Equivalents financial
"These shares include 73 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended..."
Payments tied to employee or contractor equity awards that mirror the cash dividends paid on the company’s stock; they give the holder the same economic benefit as owning the shares without transferring actual shares—often paid in cash or additional award units when the award becomes payable. Investors care because these payments affect a company’s compensation costs, cash flow and potential share dilution, and they signal how management is being rewarded and aligned with shareholders.
Restricted Stock Units financial
"DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out..."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Equity Incentive Plan financial
"granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan..."
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
tax-withholding disposition financial
"transaction_action": "tax-withholding disposition""
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Khosla Rachna

(Last)(First)(Middle)
ONE AMGEN CENTER DRIVE

(Street)
THOUSAND OAKS CALIFORNIA 91320

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
AMGEN INC [ AMGN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
SVP, Business Development
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/02/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/02/2026F117D$329.828,174D
Common Stock05/02/2026F108D$329.828,066(1)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. These shares include 73 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
/s/ Rachna Khosla05/05/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Amgen (AMGN) executive Rachna Khosla report in this Form 4?

Rachna Khosla reported that 225 Amgen shares were disposed of on May 2, 2026 to satisfy tax obligations on equity compensation. These were coded as tax-withholding transactions, not open-market sales, and she continues to hold a direct equity position in Amgen.

How many Amgen (AMGN) shares were used for tax withholding and at what price?

The filing shows 225 Amgen common shares used for tax withholding at $329.82 per share. This consisted of 108 shares in one transaction and 117 shares in another, both on May 2, 2026, reflecting non-market dispositions tied to compensation.

Do these Amgen (AMGN) Form 4 transactions represent open-market sales?

No, the transactions are coded “F,” indicating shares were withheld to pay taxes or exercise costs on equity awards. The filing explicitly describes these as tax-withholding dispositions, meaning they were not discretionary open-market sales initiated by the executive.

What is Rachna Khosla’s ownership position in Amgen (AMGN) after the reported transactions?

The Form 4 indicates that Khosla continues to directly own thousands of Amgen shares following the tax-withholding events. The reported holdings also include 73 dividend equivalents that will be paid in Amgen common stock as her restricted stock units vest.

What are dividend equivalents (DEs) mentioned in the Amgen (AMGN) Form 4 footnote?

Dividend equivalents are additional units credited on unvested restricted stock units to reflect dividends that would have been paid on underlying shares. In this case, 73 DEs will pay out in Amgen common stock on a one-to-one basis as the related RSUs vest.

Which Amgen (AMGN) compensation plan governs the reported dividend equivalents and RSUs?

The dividend equivalents and associated restricted stock units are granted under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan. That plan allows DEs to be credited and later settled in Amgen common stock based on the RSUs’ vesting schedule.